verapamil has been researched along with bifendate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, X; Lai, Y; Peng, H; Peng, S; Ren, Z; Tang, X; Zhang, Y; Zhao, Q | 1 |
| Gu, X; Lai, Y; Ma, Y; Peng, H; Peng, S; Ren, Z; Tang, X; Zhang, Y | 1 |
| Gu, X; Huang, Z; Lu, B; Luo, X; Peng, H; Peng, S; Ren, Z; Tang, X; Tian, J; Xue, R; Zhang, Y | 1 |
3 other study(ies) available for verapamil and bifendate
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potent P-glycoprotein inhibitors.
Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azepines; Biphenyl Compounds; Chemistry Techniques, Synthetic; Doxorubicin; Gene Expression Regulation; Humans; K562 Cells; Rhodamine 123; RNA, Messenger; Structure-Activity Relationship | 2012 |
Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Chalcone; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; K562 Cells; Structure-Activity Relationship | 2012 |
Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biphenyl Compounds; Cell Proliferation; Drug Resistance, Neoplasm; Heterografts; Humans; In Vitro Techniques; K562 Cells; Mice; Mice, Nude; Nitric Oxide | 2017 |